Retiring Amgen CEO Kevin Sharer to Hand Role to Bradway
This article is for subscribers only.
Kevin Sharer, who has run Amgen Inc., the world’s largest biotechnology company, for the past decade, will hand the reins to Robert Bradway, president and chief operating officer, in May.
Amgen grew under Sharer, 63, to an estimated $16 billion in annual sales from $3.6 billion in 2000. He also oversaw the debut in 2002 of Amgen’s current best selling drug, Neulasta, which is used to reduce infections in patients on chemotherapy, generating $3.56 billion in sales last year.